14 results on '"Swart RM"'
Search Results
2. Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia
- Author
-
Jansen, Gerard, Swart, RM, te Boekhorst, Peter, Internal Medicine, and Hematology
- Published
- 2011
3. Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists.
- Author
-
Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, den Hollander JG, Swart, Reinout M, van Ingen, Jakko, van Soolingen, Dick, Slingerland, Rob, Hendriks, Willem D H, and den Hollander, Jan G
- Published
- 2009
- Full Text
- View/download PDF
4. Fumarate production with Rhizopus oryzae : utilising the Crabtree effect to minimise ethanol by-product formation.
- Author
-
Swart RM, le Roux F, Naude A, de Jongh NW, and Nicol W
- Abstract
Background: The four-carbon dicarboxylic acids of the tricarboxylic acid cycle (malate, fumarate and succinate) remain promising bio-based alternatives to various precursor chemicals derived from fossil-based feed stocks. The double carbon bond in fumarate, in addition to the two terminal carboxylic groups, opens up an array of downstream reaction possibilities, where replacement options for petrochemical derived maleic anhydride are worth mentioning. To date the most promising organism for producing fumarate is Rhizopus oryzae (ATCC 20344, also referred to as Rhizopus delemar ) that naturally excretes fumarate under nitrogen-limited conditions. Fumarate excretion in R. oryzae is always associated with the co-excretion of ethanol, an unwanted metabolic product from the fermentation. Attempts to eliminate ethanol production classically focus on enhanced oxygen availability within the mycelium matrix. In this study our immobilised R. oryzae process was employed to investigate and utilise the Crabtree characteristics of the organism in order to establish the limits of ethanol by-product formation under growth and non-growth conditions., Results: All fermentations were performed with either nitrogen excess (growth phase) or nitrogen limitation (production phase) where medium replacements were done between the growth and the production phase. Initial experiments employed excess glucose for both growth and production, while the oxygen partial pressure was varied between a dissolved oxygen of 18.4% and 85%. Ethanol was formed during both growth and production phases and the oxygen partial pressure had zero influence on the response. Results clearly indicated that possible anaerobic zones within the mycelium were not responsible for ethanol formation, hinting that ethanol is formed under fully aerobic conditions as a metabolic overflow product. For Crabtree-positive organisms like Saccharomyces cerevisiae ethanol overflow is manipulated by controlling the glucose input to the fermentation. The same strategy was employed for R. oryzae for both growth and production fermentations. It was shown that all ethanol can be eliminated during growth for a glucose addition rate of 0.07 g L - 1 h - 1 . The production phase behaved in a similar manner, where glucose addition of 0.197 g L - 1 h - 1 resulted in fumarate production of 0.150 g L - 1 h - 1 and a yield of 0.802 g g - 1 fumarate on glucose. Further investigation into the effect of glucose addition revealed that ethanol overflow commences at a glucose addition rate of 0.395 g g - 1 h - 1 on biomass, while the maximum glucose uptake rate was established to be between 0.426 and 0.533 g g - 1 h - 1 ., Conclusions: The results conclusively prove that R. oryzae is a Crabtree-positive organism and that the characteristic can be utilised to completely discard ethanol by-product formation. A state referred to as "homofumarate production" was illustrated, where all carbon input exits the cell as either fumarate or respiratory CO 2 . The highest biomass-based "homofumarate production": rate of 0.243 g g - 1 h - 1 achieved a yield of 0.802 g g - 1 on glucose, indicating the bounds for developing an ethanol free process. The control strategy employed in this study in conjunction with the uncomplicated scalability of the immobilised process provides new direction for further developing bio-fumarate production., Competing Interests: Competing interestsThe authors declare that they have no competing interests., (© The Author(s) 2020.)
- Published
- 2020
- Full Text
- View/download PDF
5. Acute kidney injury during therapy with an antisense oligonucleotide directed against PCSK9.
- Author
-
van Poelgeest EP, Swart RM, Betjes MG, Moerland M, Weening JJ, Tessier Y, Hodges MR, Levin AA, and Burggraaf J
- Subjects
- Female, Humans, Middle Aged, Oligonucleotides, Antisense therapeutic use, Proprotein Convertase 9, Proprotein Convertases therapeutic use, Serine Endopeptidases therapeutic use, Acute Kidney Injury chemically induced, Oligonucleotides, Antisense adverse effects, Proprotein Convertases adverse effects, Serine Endopeptidases adverse effects
- Abstract
Antisense oligonucleotides have been explored widely in clinical trials and generally are considered to be nontoxic for the kidney, even at high concentrations. We report a case of toxic acute tubular injury in a healthy 56-year-old female volunteer after a pharmacologically active dose of a locked nucleic acid antisense oligonucleotide was administered. The patient received 3 weekly subcutaneous doses of experimental drug SPC5001, an antisense oligonucleotide directed against PCSK9 (proprotein convertase subtilisin/kexin type 9) that is under investigation as an agent to reduce low-density lipoprotein cholesterol levels. Five days after the last dose, the patient's serum creatinine level increased from 0.81 mg/dL at baseline (corresponding to an estimated glomerular filtration rate [eGFR] of 78 mL/min/1.73 m(2)) to 2.67 mg/dL (eGFR, 20 mL/min/1.73 m(2)), and this increase coincided with the presence of white blood cells, granular casts, and minimal hematuria on urine microscopy. The patient's serum creatinine level peaked at 3.81 mg/dL (eGFR, 13 mL/min/1.73 m(2)) 1 week after the last oligonucleotide dose. Kidney biopsy showed multifocal tubular necrosis and signs of oligonucleotide accumulation. Upon conservative treatment, the patient's serum creatinine level gradually decreased and reached her baseline level 44 days after the last oligonucleotide was administered. The patient recovered fully and kidney function was normal at every follow-up visit., (Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
6. [Thrombocytopenia during pregnancy].
- Author
-
Rokx C, Swart RM, van Houten AA, Leys MB, Duvekot JJ, and Te Boekhorst PA
- Subjects
- Adrenal Cortex Hormones therapeutic use, Adult, Female, Fetal Membranes, Premature Rupture etiology, Fetal Membranes, Premature Rupture prevention & control, Humans, Immunoglobulins therapeutic use, Obstetric Labor, Premature etiology, Platelet Count, Pregnancy, Pregnancy Complications, Hematologic epidemiology, Pregnancy Complications, Hematologic therapy, Pregnancy Outcome, Prenatal Care, Thrombocytopenia epidemiology, Thrombocytopenia therapy, Pregnancy Complications, Hematologic diagnosis, Thrombocytopenia diagnosis
- Abstract
Thrombocytopenia during pregnancy can be caused by a broad variety of disorders. An early diagnosis is essential for timely and adequate therapy. In cases of severe thrombocytopenia, a multidisciplinary approach by a team of obstetricians, haematologists and anaesthesiologists is needed. We describe a 30-year-old patient at a gestational age of 35 weeks who presented with preterm rupture of membranes. Coincidentally, she also had severe thrombocytopenia that proved to be due to immune thrombocytopenia (ITP). The severe thrombocytopenia persisted despite standard first-line treatment with corticosteroids and intravenous immunoglobulins. Based on this case report we discuss the differential diagnosis of thrombocytopenia during pregnancy with a focus on the management of ITP in pregnant women.
- Published
- 2013
7. Thrombopoietin-receptor agonists for immune thrombocytopenia.
- Author
-
Jansen AJ, Swart RM, and te Boekhorst PA
- Subjects
- Female, Humans, Autoimmune Diseases drug therapy, Benzoates therapeutic use, Hydrazines therapeutic use, Pyrazoles therapeutic use, Receptors, Fc therapeutic use, Receptors, Thrombopoietin agonists, Recombinant Fusion Proteins therapeutic use, Thrombocytopenia drug therapy, Thrombopoietin therapeutic use
- Published
- 2011
- Full Text
- View/download PDF
8. Using the outer coordination sphere to tune the strength of metal extractants.
- Author
-
Forgan RS, Roach BD, Wood PA, White FJ, Campbell J, Henderson DK, Kamenetzky E, McAllister FE, Parsons S, Pidcock E, Richardson P, Swart RM, and Tasker PA
- Abstract
A series of 3-substituted salicylaldoximes has been used to demonstrate the importance of outer-sphere interactions on the efficacy of solvent extractants that are used to produce approximately one-quarter of the world's copper. The distribution coefficient for extraction of copper by 5-tert-butyl-3-X-salicylaldoximes (X = H, Me, (t)Bu, NO(2), Cl, Br, OMe) varies by more than two orders of magnitude. X-ray structure determinations of preorganized free ligand dimers (10 new structures are reported) indicate that substituents with a hydrogen-bond acceptor atom attached to the 3-carbon atom, ortho to the phenolic oxygen, buttress the intermolecular hydrogen bond from the oximic proton. Density functional theory calculations demonstrate that this hydrogen-bond buttressing is maintained in copper(II) complexes and contributes significantly to their relative stabilities in energy-minimized gas-phase structures. A remarkable correlation between the order of the calculated enthalpies of formation of the copper complexes in the gas phase and the observed strength of the ligands as copper solvent extractants is ascribed to the low solvation energies of species in the water-immiscible phase and/or the similarities of the solvation enthalpies of the preorganized ligand dimers and their copper(II) complexes.
- Published
- 2011
- Full Text
- View/download PDF
9. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation.
- Author
-
Swart RM, Hoorn EJ, Betjes MG, and Zietse R
- Subjects
- Cytokines physiology, Humans, Signal Transduction physiology, Vasopressins physiology, Hyponatremia physiopathology, Inflammation physiopathology, Interleukin-6 physiology, Water-Electrolyte Balance physiology
- Abstract
Although hyponatremia is a recognized complication of several inflammatory diseases, its pathophysiology in this setting has remained elusive until recently. A growing body of evidence now points to an important role for interleukin-6 in the non-osmotic release of vasopressin. Here, we review this evidence by exploring the immuno-neuroendocrine pathways connecting interleukin-6 with vasopressin. The importance of these connections extends to several clinical scenarios of hyponatremia and inflammation, including hospital-acquired hyponatremia, postoperative hyponatremia, exercise-associated hyponatremia, and hyponatremia in the elderly. Besides insights in pathophysiology, the recognition of the propensity for antidiuresis during inflammation is also important with regard to monitoring patients and selecting the appropriate intravenous fluid regimen, for which recommendations are provided., (Copyright © 2010 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
10. Collision induced dissociation (CID) to probe the outer sphere coordination chemistry of bis-salicylaldoximate complexes.
- Author
-
Roach BD, Forgan RS, Tasker PA, Swart RM, Campbell J, McAllister FE, Stopford AP, and Duncombe BJ
- Abstract
Ligand-ligand interactions in the outer coordination sphere make an important contribution to the effects of 3-substituents on the stabilities of anionic Cu(II) salicylaldoximato complexes [CuL(L-H)](-). When substituents contain a different number of bonds the interpretation of CID tandem mass spectrometry must take into account the ability of ions to redistribute energy acquired in collisions within different numbers of vibrational modes.
- Published
- 2010
- Full Text
- View/download PDF
11. Polyacidic multiloading metal extractants.
- Author
-
Gordon RJ, Campbell J, Henderson DK, Henry DC, Swart RM, Tasker PA, White FJ, Wood JL, and Yellowlees LJ
- Abstract
Novel polynucleating, di- and tri-acidic ligands have been designed to increase the molar and mass transport efficiencies for the recovery of base metals by solvent extraction.
- Published
- 2008
- Full Text
- View/download PDF
12. Hyponatremia due to reset osmostat in dementia with lewy bodies.
- Author
-
Hoorn EJ, Swart RM, Westerink M, van den Dorpel MA, Berghout A, and Bakker JJ
- Subjects
- Aged, Female, Humans, Inappropriate ADH Syndrome diagnosis, Inappropriate ADH Syndrome etiology, Lewy Body Disease complications
- Published
- 2008
- Full Text
- View/download PDF
13. Supramolecular chemistry in metal recovery; H-bond buttressing to tune extractant strength.
- Author
-
Forgan RS, Wood PA, Campbell J, Henderson DK, McAllister FE, Parsons S, Pidcock E, Swart RM, and Tasker PA
- Published
- 2007
- Full Text
- View/download PDF
14. The fluorescence and circular dichroism of proteins in reverse micelles: application to the photophysics of human serum albumin and N-acetyl-L-tryptophanamide.
- Author
-
Davis DM, McLoskey D, Birch DJ, Gellert PR, Kittlety RS, and Swart RM
- Subjects
- Chemical Phenomena, Chemistry, Physical, Circular Dichroism, Fluorescence Polarization, Humans, Photochemistry, Spectrometry, Fluorescence, Tryptophan chemistry, Micelles, Serum Albumin chemistry, Tryptophan analogs & derivatives
- Abstract
Evidence is presented that a compartmentalised protein exists in its native state only within a particular size of aqueous cavity. This behaviour is shown to exist in AOT reverse micelles using fluorescence quenching and circular dichroism (CD) studies of human serum albumin (HSA). In particular, far ultraviolet CD measurements show that a reduction in quencher accessibility to the fluorophore is consistent with the protein being nearest to its native conformation at a waterpool size of around 80 A diameter. We also show that the biexponential fluorescence decay of N-acetyl-L-tryptophanamide (NATA) in AOT reverse micelles arises from the probe being located in two distinct sites within the interfacial region. The more viscous of these two sites is located on the waterpool side of the interface and the other is located on the oil side of the interface.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.